These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11916967)

  • 1. Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells.
    Pawlowski JE; Ertel JR; Allen MP; Xu M; Butler C; Wilson EM; Wierman ME
    J Biol Chem; 2002 Jun; 277(23):20702-10. PubMed ID: 11916967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli.
    Mulholland DJ; Cheng H; Reid K; Rennie PS; Nelson CC
    J Biol Chem; 2002 May; 277(20):17933-43. PubMed ID: 11856748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
    Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
    Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
    Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
    Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
    J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
    Chesire DR; Isaacs WB
    Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
    Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.
    Masiello D; Chen SY; Xu Y; Verhoeven MC; Choi E; Hollenberg AN; Balk SP
    Mol Endocrinol; 2004 Oct; 18(10):2388-401. PubMed ID: 15256534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking beta-catenin to androgen-signaling pathway.
    Yang F; Li X; Sharma M; Sasaki CY; Longo DL; Lim B; Sun Z
    J Biol Chem; 2002 Mar; 277(13):11336-44. PubMed ID: 11792709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M; Sun Z
    Mol Endocrinol; 2005 Feb; 19(2):391-8. PubMed ID: 15514031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
    Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
    Ikonen T; Palvimo JJ; Jänne OA
    J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-repression of beta-catenin activity by nuclear receptors.
    Shah S; Hecht A; Pestell R; Byers SW
    J Biol Chem; 2003 Nov; 278(48):48137-45. PubMed ID: 12972427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones.
    Kemppainen JA; Lane MV; Sar M; Wilson EM
    J Biol Chem; 1992 Jan; 267(2):968-74. PubMed ID: 1730684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway.
    Rigas AC; Ozanne DM; Neal DE; Robson CN
    J Biol Chem; 2003 Nov; 278(46):46087-93. PubMed ID: 12958311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
    Chesire DR; Ewing CM; Gage WR; Isaacs WB
    Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
    Truica CI; Byers S; Gelmann EP
    Cancer Res; 2000 Sep; 60(17):4709-13. PubMed ID: 10987273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.
    Singh R; Artaza JN; Taylor WE; Braga M; Yuan X; Gonzalez-Cadavid NF; Bhasin S
    Endocrinology; 2006 Jan; 147(1):141-54. PubMed ID: 16210377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.